Peritoneal Dialysis Registration System (PERSIST)

Condition(s) studied

Investigational drug(s) / intervention(s)

No intervention: Registration of all PD patients in the First Affiliated Hospital of Sun Yat-sen University and other hospitals，which have signed the contract in China.

Study summary

Brief Summary: The investigators are registering all PD patients at recruited hospitals and developing a PD database in China. Patients will be followed up every 3 months, and both baseline and follow-up information will be collected and input into the registration system. The patient survival, technical survival, peritonitis rate, longitudinal changes of residual renal function and peritoneum function, and quality of life for PD patients, etc, will be compared using the PD database.

Eligibility

Primary outcome measure(s)

• Patient survival of PD patients — 10 years
  Patient survival including all-cause and cardiovascular mortality.

Trial sites (1)

More Sun Yat-sen University trials in China